Corneal intrastromal voriconazole as an adjunctive approach for treatment of recalcitrant fungal ulcers in Tanta University Hospitals
Delta Journal of Ophthalmology · 2026-10 · 27 (4) · 253-259
DOI: 10.4103/djo.djo_25_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Delta Journal of Ophthalmology, online erschienen am 19.11.2026. Verfasst von Hager M. Abo Elazm und 3 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Resistant fungal corneal ulcers pose a therapeutic challenge and may fail to respond to the conventional topical antifungal therapy. Intrastromal voriconazole (ISV) injection has been proposed as an adjunctive treatment to improve the local drug delivery and clinical outcome.
Objective
The aim of this study was to assess the efficacy of ISV in the treatment of resistant fungal corneal ulcers nonresponsive to conventional topical antifungal therapy. Patients and methods This is a prospective, nonrandomized, comparative interventional study that included 30 eyes of 30 patients with resistant fungal corneal ulcers attending the Cornea Unit, Tanta University Ophthalmology Hospital, Tanta, Egypt from October 2023 to September 2024. The included patients were allocated into two groups: group 1 (topical treatment, n =15) who received topical voriconazole, whereas group 2 (ISV treatment, n =15) who received ISV (50 μg/0.1 ml) in addition to the topical voriconazole. The evaluated outcomes included the visual acuity (VA), ulcer characteristics, hypopyon, and healing time.
Results
Moderate-sized central corneal ulcers predominated in both groups. Hypopyon was more frequent in the ISV group than in the topical group (80.0 vs. 46.7%, P =0.058). The distribution of the VA-line gain did not differ significantly between the two groups ( P =0.057). However, two or more lines were gained by 60.0% of the ISV-treated eyes compared to 20.0% of the topically treated eyes. The mean healing time was significantly shorter in the ISV group (2.7±0.90 weeks) than in the topical group (3.7±1.11 weeks), ( P =0.011). Healing within 2 weeks occurred in 53.3% of the ISV-treated eyes compared to 20.0% of the topically treated eyes ( P =0.083).
Conclusion
ISV combined with topical voriconazole was associated with significantly shorter healing time and a clinically favorable, although statistically nonsignificant outcome, and a trend toward greater VA improvement compared with the topical therapy alone.
Zitieren
APA
Elazm, H. M. A., Hasby, H. A., Khater, M. M., & El-Marakby, O. O. (2026). Corneal intrastromal voriconazole as an adjunctive approach for treatment of recalcitrant fungal ulcers in Tanta University Hospitals. Delta Journal of Ophthalmology, 27(4), 253-259. https://doi.org/10.4103/djo.djo_25_26
Vancouver
Elazm HMA, Hasby HA, Khater MM, El-Marakby OO. Corneal intrastromal voriconazole as an adjunctive approach for treatment of recalcitrant fungal ulcers in Tanta University Hospitals. Delta Journal of Ophthalmology. 2026;27(4):253-259. doi:10.4103/djo.djo_25_26
BibTeX
@article{Elazm2026,
author = {Elazm, Hager M. Abo and Hasby, Hesham A. and Khater, Mohamed M. and El-Marakby, Omnia O.},
title = {Corneal intrastromal voriconazole as an adjunctive approach for treatment of recalcitrant fungal ulcers in Tanta University Hospitals},
journal = {Delta Journal of Ophthalmology},
year = {2026},
volume = {27},
number = {4},
pages = {253--259},
doi = {10.4103/djo.djo_25_26}
}
EUVIMED